20981 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interferons [IFN] IFN-gamma
Activatable Cytokine Polypeptides and Methods of Use Thereof
#2DELIVERY OF THERAPEUTIC PROTEINS
#3IMPLANTABLE SCAFFOLDS AND METHODS OF USE
#4IMMUNOGENIC PEPTIDES SPECIFIC TO BCMA AND TACI ANTIGENS FOR TREATMENT OF CANCER
#5COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND INTERFERON GAMMA
#6System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein
#7Combination treatment for atopic dermatitis
#8Recombinant Viral Particle for Gene and/or Cellular Therapy
#9METHODS OF FABRICATING THERMOSENSITIVE HYDROGELS AND USES THEREOF FOR INDUCING CHRONIC GLAUCOMA ANIMAL MODELS
#10ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF
#11TREATMENT OF MHC-I NEGATIVE TUMORS WITH NK AND T CELLS
#12MANUFACTURING SYSTEMS AND METHODS FOR CELLULAR THERAPEUTIC PLATFORMS
#13BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME
#14SYSTEMS AND METHODS FOR SYMPATHETIC CARDIOPULMONARY NEUROMODULATION
#15ONCOLYTIC VIRUS THERAPY
#16Compositions and Methods for Activating Natural Killer Cells
#17COMPOSITION FOR REDUCING SIZE OR VOLUME OF TARGET TISSUE OR KIT INCLUDING SAME
#18POLYMER ENGINEERED FORMS OF INTERFERON-GAMMA AND METHODS OF USE
#19INTERFERON-BASED CANCER TREATMENT METHOD, AND PHARMACEUTICAL COMBINATION
#20THERAPEUTIC COMPOSITION AND METHOD COMBINING MULTIPLEX IMMUNOTHERAPY WITH CANCER VACCINE FOR THE TREATMENT OF CANCER
#21THERAPEUTIC NUCLEIC ACID MOLECULE, MIXTURE, AND DRUG, AND USE THEREOF IN TREATING SOLID TUMOR
#22ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#23ALUMINUM NANOCRYSTALLINE COMPOSITE IMMUNE DRUG AND PREPARATION METHOD THEREFOR AND USE THEREOF
#24PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#25PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#26METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#27LEUKEMIA-RELATED MARKER AND USE THEREOF
#28COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS WITH IMMUNE CHECKPOINT INHIBITORS AND MHC CLASS I ACTIVATORS
#29PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#30METHOD FOR TREATING INFECTIOUS DISEASE
#31METHODS AND COMPOSITIONS FOR ENHANCEMENT OF TUMOR IMMUNOGENICITY AND STIMULATING ANTI-TUMOR IMMUNE RESPONSES IN AN ANIMAL
#32A MODIFIED PROTEIN OF INTERFERON GAMMA AND ITS USE THEREOF
#33NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF
#34FUSION PROTEIN OF INTERFERON (IFN) AND ANTI-PD-L1 ANTIBODY AND USE THEREOF
#35INHALED INTERFERONS FOR VIRAL RESPIRATORY INFECTIONS
#36OXAZAPHOSPHORINE ANTIBODY DRUG CONJUGATES AND METHODS OF USE
#37MULTIVALENT INTERFERON PARTICLES COMPOSITIONS AND METHODS OF USE
#38ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
#39COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#40METHODS OF USING SPLICING MODULATORS
#41CXC CHEMOKINE AGONISTS AND ANTAGONISTS IN COVID-19 DISEASE AND DIAGNOSTIC ASSAYS
#42METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#43RECOMBINANT POLYPEPTIDES AND COMBINATIONS FOR USE IN THE TREATMENT OF CANCER
#44COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS
#45PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES
#46METHODS FOR INDUCING AN IMMUNE RESPONSE BY ADMINISTERING ACTIVATED MESENCHYMAL STEM CELLS
#47PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES
#48TCR MIMIC MONOCLONAL ANTIBODIES REACTIVE WITH THE PHOSPHO-NEOANTIGEN PIRS2/HLA-A*02:01 COMPLEX AND USES THEREOF
#49COMPOSITIONS AND METHODS COMPRISING PROTEASE-ACTIVATED THERAPEUTIC AGENTS
#50METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#51INDUCIBLE CYTOKINE PRODRUG AND PD-1/PD-L1 COMBINATION THERAPY
#52ACTIVATABLE INTERFERON POLYPEPTIDES AND METHODS OF USE THEREOF
#53GENE THERAPY FOR IMMUNO-ONCOLOGY APPLICATIONS
#54PERSONALIZED IMMUNOTHERAPY USING INTESTINAL METABOLITES
#55MODULATION OF TUMOR MICROENVIRONMENT TO AUGMENT EFFICACY OF IMMUNOTHERAPY
#56CHIMERIC BROAD-SPECTRUM ONCOLYTIC ADENOVIRUS WITH MULTIPLE MECHANISMS SYNERGIZING WITH AND ENHANCING EFFICACY OF IMMUNOTHERAPY, AND APPLICATION THEREOF IN TUMOR TREATMENT
#57INHIBITION OF KDM5A FOR PROMOTING ANTIGEN PRESENTATION, INCREASING CD8+ T CELL INFILTRATION AND BOOSTING ANTI-TUMOR IMMUNE RESPONSE
#58Method for preparing a transformed, interferon gamma (IFNG)-producing bacterium
#59STING LEVELS AS A BIOMARKER FOR CANCER IMMUNOTHERAPY
#60TUMOR PHENOTYPE PREDICTION USING GENOMIC ANALYSES INDICATIVE OF DIGITAL-PATHOLOGY METRICS
#61CHIMERIC ANTIGEN RECEPTORS THAT BIND PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME)/HLA-A2 TO TREAT CANCER
#62METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#63Activatable cytokine polypeptides and methods of use thereof
#64T CELL RECEPTORS AND USES THEREOF
#65SYNERGISTIC INDUCTION OF IMMUNITY AGAINST RNA VIRUSES
#66METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#67METHODS FOR DE-CLOAKING CANCER FROM THE IMMUNE SYSTEM THROUGH DOWNREGULATION OF CANCER-PRODUCED PREGNANCY SPECIFIC GLYCOPROTEIN
#68COMPOSITIONS FOR AND METHODS OF TREATMENT WITH MUTANT A1 ADENOSINE RECEPTOR PLASMID cDNAs
#69HLA-A24 AGONIST EPITOPES OF MUC1-C ONCOPROTEIN AND COMPOSITIONS AND METHODS OF USE
#70FUSION PROTEIN ENHANCING CELL THERAPY
#71NANOPARTICLES AND METHODS OF MANUFACTURE THEREOF
#72APPLICATION OF IFN-y IN PREPARING ANTI-TUMOR ADJUVANT DRUG
#73BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME
#74CERTAIN ARYL PLADIENOLIDE COMPOUNDS AND METHODS OF USE
#75Coronavirus T Cell Epitopes and Uses Thereof
#76NANOPARTICLE COMPLEX WITH DEFINED SIZES
#77IMMUNOGENIC PEPTIDES SPECIFIC TO BCMA AND TACI ANTIGENS FOR TREATMENT OF CANCER
#78METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#79Methods for handling biological drugs containing living cells
#80COMPOSITIONS AND METHODS FOR TREATMENT OF GENE THERAPY PATIENTS
#81Methods for handling biological drugs containing living cells
#82Liposomes for targeting tumor-associated macrophages
#83PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#84HUMAN ANTI-INFLAMMATORY PEPTIDES FOR THE INHALATORY TREATMENT OF INFLAMMATORY PULMONARY ISSUES
#85Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#86VISMODEGIB IN COMBINATION WITH A REPLICATION-DEFICIENT TYPE 5 ADENOVIRUS FOR EXPRESSION OF INTERFERON GAMMA FOR THE TREATMENT OF SKIN CANCER
#87USE OF ADEFOVIR DIPIVOXIL AND STRUCTURAL ANALOG THEREOF FOR TREATING PSEUDORABIES VIRUS
#88Activatable cytokine polypeptides and methods of use thereof
#89ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
#90PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#91Recombinant Viral Particle for Gene and/or Cellular Therapy
#92PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#93PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#94PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#95PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#96Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#97PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#98Use of Interferon in Preparing Drug for Preventing Coronavirus Infection or Preventing Disease Caused by Coronavirus Infection
#99PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#100Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#101PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#102PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#103Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#104PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#105Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#106BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME
#107Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#108Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#109Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#110Transformed, salmo salar interferon gamma (ifng)-producing lactococcus lactis bacterium, food and composition comprising same, for immunostimulation in aquaculture species
#111METHODS TO INCREASE THE SENSITIVITY AND REVERSING THE RESISTANCE TO DRUGS
#112CHIMERIC ANTIGEN RECEPTOR AND APPLICATION THEREOF
#113METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#114TREATMENT OF CANCERS WITH GM-CSF ANTAGONISTS
#115Exosome-based cancer assays
#116EXTENDED RELEASE IMMUNOMODULATORY IMPLANT TO FACILITATE BONE MORPHOGENESIS
#117METHOD FOR THE MANUFACTURE OF A DOSAGE FORM WITH MUCOADHESIVE PROPERTIES FOR BUCCAL ADMINISTRATION OF BIOLOGICS
#118Methods and compositions for liquidation of tumors
#119Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#120Therapeutic composition and method combining multiplex immunotherapy with cancer vaccine for the treatment of cancer
#121MICROLUMENAL TARGETING OF CANCER CELLS
#122COMBINATION THERAPY WITH CD13-TARGETED CHIMERIC PROTEINS OR CHIMERIC PROTEIN COMPLEXES
#123RETROVIRAL VECTOR HAVING IMMUNE-STIMULATING ACTIVITY
#124INDUCING FAVORABLE EFFECTS ON TUMOR MICROENVIRONMENT VIA ADMINISTRATION OF NANOPARTICLE COMPOSITIONS
#125MODIFIED AAV VECTORS THAT DAMPEN THE HUMORAL IMMUNE RESPONSE
#126Combination treatment for atopic dermatitis
#127COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS
#128Compounds and pharmaceutical uses thereof
#129EXTENDED RELEASE IMMUNOMODULATORY IMPLANT TO FACILITATE BONE MORPHOGENESIS
#130ANUCLEATE CELL-DERIVED VACCINES
#131RESIQUIMOD TOPICAL AND INJECTABLE COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC SKIN CONDITIONS
#132HARNESSING INFLAMMATION TO TREAT NEURODEVELOPMENTAL DISORDERS
#133REGULATION OF A FOREIGN BODY RESPONSE
#134DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES
#135COMPOSITIONS AND METHODS FOR PREVENTING AND/OR INHIBITING VIRAL INFECTION AND SPREAD
#136CONSTITUTIVE EXPRESSION OF COSTIMULATORY LIGANDS ON ADOPTIVELY TRANSFERRED T LYMPHOCYTES
#137Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment of Cancer
#138Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#139Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#140Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#141Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#142METHODS FOR ENHANCING CANCER IMMUNOTHERAPY
#143CELL-FREE COMPOSITIONS AND METHODS FOR RESTORATION OR ENHANCEMENT OF TISSUE FUNCTION
#144Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#145Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#146THERAPEUTIC COMPOSITIONS AND RELATED METHODS
#147Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#148Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#149Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#150Methods of using splicing modulators
#151TISSUE HEALING AGENT
#152Vaccine to pathogenic immune activation cells during infections
#153Methods for the preparation of a pharmaceutical-vesicle formulation and associated products and uses
#154Netrin G1 as a biomarker for enhancing tumor treatment efficacy
#155INTERFERON-GAMMA BIASED AGONISTS
#156ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#157NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF
#158Compositions and methods of enhancing anti-tumor response using hybrid neutrophils
#159NOVEL METHODS FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS
#160HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
#161COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS
#162Compounds and pharmaceutical uses thereof
#163COMPOSITIONS AND METHODS FOR TREATMENT OF INTRACELLULAR DAMAGE AND BACTERIAL INFECTION
#164Methods for inducing an immune response by administering activated mesenchymal stem cells
#165Methods of immunotherapy
#166Methods of administering mesenchymal stem cells activated by cytokines for enhancing immunosuppression
#167METHODS OF ACTIVATING CELLS VIA PTP 1B INHIBITION
#168TREATMENTS FOR MIGRAINE AND RELATED DISORDERS
#169TREATMENT OF MEMBRANOUS NEPHROPATHY, IGG4-RELATED DISEASE, AND ANTIPHOSPHOLIPID SYNDROME USING BTK INHIBITOR 2-[(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE
#170Certain aryl pladienolide compounds and methods of use
#171Fusion protein of interferon (IFN) and anti-PD-L1 antibody and use thereof
#172METHODS, COMPUTER-READABLE MEDIA, AND SYSTEMS FOR ASSESSING SAMPLES AND WOUNDS, PREDICTING WHETHER A WOUND WILL HEAL, AND MONITORING EFFECTIVENESS OF A TREATMENT
#173Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#174PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#175METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#176Stabilized Composition
#177BIO-MIMETIC FORMULATION
#178PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#179CD8+ t cell based immunosuppressive tumor microenvironment detection method
#180Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#181Methods and agents for treating infections
#182COMBINATION THERAPY FOR THE TREATMENT OF MIGRAINES
#183COUPLED REDIRECTED CELLS AND USES THEREOF
#184IN SITU METHODS OF INDUCING OF IMMUNE RESPONSE
#185COMPOSITIONS FOR TREATING INFECTIVE ARTERIAL DISEASES AND RELATED CONDITIONS
#186ENHANCED VIRAL DELIVERY FORMULATION
#187STING levels as a biomarker for cancer immunotherapy
#188Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy
#189Modular Particulars for Immunotherapy
#190Immunoregulatory role of 3-OH-kynurenamine and uses thereof
#191Activators of CXCR3 for the treatment of angiopathies of the eye
#192PRODUCTION AND USE OF EXTRACELLULAR VESICLES
#193METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING METASTATIC TUMORS
#194COMPOSITIONS AND METHODS RELATING TO MACROPHAGES AND/OR MONOCYTES WITH ADHERED PARTICLES
#195Immunogenic peptides specific to BCMA and TACI antigens
#196USES OF PD-1/PD-L1 INHIBITORS AND/OR CTLA-4 INHIBITORS WITH A BIOLOGIC CONTAINING MULTIPLE CYTOKINE COMPONENTS TO TREAT CANCER
#197Methods for administering STING agonists
#198Biomarkers and combination therapies using oncolytic virus and immunomodulation
#199System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein
#200Extended release immunomodulatory implant to facilitate bone morphogenesis
#201Vaccine to pathogenic immune activation cells during infections
#202METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#203Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovarian cancer
#204Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#205Thermostable Composition Having Antiviral and Antibacterial Activity and the Use Thereof
#206Methods and compositions for treatment of cancer
#207Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
#208HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
#209TISSUE HEALING AGENT
#210METHODS OF TREATING A MAMMAL SUFFERING FROM OR SUSCEPTIBLE TO AN IMMUNE REACTION TO DRUG TREATMENT
#211NRF2 Screening Assays and Related Methods and Compositions
#212Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#213ONCOLYTIC VIRUS THERAPY
#214Interferon Analogs
#215Combination treatment for atopic dermatitis
#216TREATMENTS FOR MIGRAINE AND RELATED DISORDERS
#217COMBINATION THERAPIES FOR ERADICATING FLAVIVIRUS INFECTIONS IN SUBJECTS
#218Compositions for biological systems and methods for preparing and using the same
#219Methods for handling biological drugs containing living cells
#220COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS BY MODULATING PROTEIN TYROSINE PHOSPHATASE 13 (PTPN13)
#221Composition for inhibiting survival or growth of tubercle bacillus by adjusting polarization of macrophage, and method using same
#222Engineered CD46-specific effector cells and uses thereof in the treatment of cancer
#223BIOMARKERS AND COMBINATION THERAPIES USING ONCOLYTIC VIRUS AND IMMUNOMODULATION
#224Methods of treating cancer
#225Treating cancer using a blautia strain
#226BIO-MIMETIC FORMULATION
#227Systems and methods for cardiac plexus neuromodulation
#228Detection of CD5 and methods and compositions for modulating CD5
#229AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS
#230Anti-CSPG4 fusions with interferon for the treatment of malignancy
#231ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#232MACROPHAGE STIMULATION IN CD47 BLOCKADE THERAPY
#233SRC INHIBITOR TO BLOCK CELL SURFACE GRP78 EXPRESSION
#234Methods of producing activated mesenchymal stem cells
#235Method of Ex Vivo Enhancement of Immune Cell Activity for Cancer Immunotherapy with a Small Molecule Ablative Compound
#236Individualized Immunomodulation Therapy for Neurodegenerative Disorders, CNS Injury and Age-Related Dementia
#237Nucleic acids encoding HLA-A24 agonist epitopes of MUC1-C oncoprotein
#238Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
#239Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#240COMPOSITIONS AND METHODS FOR PRESERVING CELLS OF THE EYE
#241Interferon analogs
#242ACTIVATORS OF CXCR3 FOR THE TREATMENT OF ANGIOPATHIES OF THE EYE
#243Compositions for biological systems and methods for preparing and using the same
#244NRF2 Screening Assays and Related Methods and Compositions
#245COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS
#246Nanoparticulate compositions comprising interferon gamma and losartan for immunotherapy
#247Resiquimod topical and injectable compositions for the treatment of neoplastic skin conditions
#248COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#249METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#250CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
#251SYSTEMS AND METHODS FOR SYMPATHETIC CARDIOPULMONARY NEUROMODULATION
#252COMPOSITIONS AND METHODS RELATED TO GRAFT VERSUS HOST DISEASE AND TREATMENTS THEREOF
#253METHODS AND ASSAYS RELATING TO MACROPHAGE DIFFERENTIATION
#254Method of treating androgen receptor negative prostate tumors and their metastases
#255COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#256Use of atpenin to activate innate immunity
#257Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine
#258Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
#259Treatments for migraine and related disorders
#260METHODS OF INDUCING INDOLAMINE 2,3 - DIOXYGENASE (IDO)
#261COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS BY MODULATING PROTEIN TYROSINE PHOSPHATASE 13 (PTPN13)
#262Compositions and methods for treatment of intracellular damage and bacterial infection
#263INDUCTION OF TOLERANCE IN LUNG ALLOGRAFT TRANSPLANTATION
#264Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma
#265METHODS OF TREATING FRIEDREICH'S ATAXIA USING SRC INHIBITORS
#266Co-expression plasmid
#267METHODS, COMPUTER-READABLE MEDIA, AND SYSTEMS FOR ASSESSING SAMPLES AND WOUNDS, PREDICTING WHETHER A WOUND WILL HEAL, AND MONITORING EFFECTIVENESS OF A TREATMENT
#268T-cell redirecting bispecific antibodies for treatment of disease
#269Human amniotic fluid preparation having long-term stability
#270Combined therapy of alpha-1-antitrypsin and temporal T-cell depletion for preventing graft rejection
#271Retroviral vector having immune-stimulating activity
#272Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compound
#273Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors
#274Combination therapy with double negative T-cells
#275HPV vaccines and methods of use thereof
#276Breast cancer vaccines and methods of use thereof
#277Lipid vesicle compositions and methods of use
#278Methods of treating coronavirus infection
#279T-cell redirecting bispecific antibodies for treatment of disease
#280COMBINATION OF IMMUNOMODULATORY AGENT WITH PD-1 or PD-L1 CHECKPOINT INHIBITORS IN THE TREATMENT OF CANCER
#281Method for Cancer Therapy Based on Co-Administration of a Parvovirus and a Cytokine
#282Activators of CXCR3 for the treatment of angiopathies of the eye
#283Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy
#284Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
#285Compositions and methods for treating melanoma
#286Systems and methods for sympathetic cardiopulmonary neuromodulation
#287Method of immunotherapy for treatment of human papillomavirus infection
#288Modular particles for immunotherapy
#289Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)
#290TYPE I INTERFERON MIMETICS AS THERAPEUTICS FOR CANCER, VIRAL INFECTIONS, AND OTHER DISEASES
#291Treatments for migraine and related disorders
#292Methods for the treatment of hepatitis B and hepatitis D infections
#293HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
#294INHALED AEROSOLIZED IMMUNO-CHEMOTHERAPY FOR THE TREATEMENT OF MDR TB
#295Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#296Hepatitis C virus inhibitors
#297SCAFFOLDS CONTAINING CYTOKINES FOR TISSUE ENGINEERING
#298METHOD OF INHIBITING BODY CAVITY FLUID ACCUMULATION
#299T-cell redirecting bispecific antibodies for treatment of disease
#300TRACKING DONOR-REACTIVE TCR AS A BIOMARKER IN TRANSPLANTATION